In addition to ESCC, increased expression of GPC1 has been reported in pancreatic cancer, breast cancer and glioma and shown to promote the mitogenic, metastatic and angiogenic properties of cancers [6, 21–24]. Here, GPC1 is linked to breast carcinoma.